Detalles de la búsqueda
1.
Evolution of the Innovative Therapies for Children With Cancer Consortium Trial Portfolio for Drug Development for Children With Cancer.
J Clin Oncol;
: JCO2301237, 2024 May 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-38743911
2.
Bevacizumab, Irinotecan, or Topotecan Added to Temozolomide for Children With Relapsed and Refractory Neuroblastoma: Results of the ITCC-SIOPEN BEACON-Neuroblastoma Trial.
J Clin Oncol;
42(10): 1135-1145, 2024 Apr 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-38190578
3.
Impact of ACCELERATE Paediatric Strategy Forums: a review of the value of multi-stakeholder meetings in oncology drug development.
J Natl Cancer Inst;
116(2): 200-207, 2024 Feb 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-37975877
4.
Rescuing Drugs That are Discontinued in Adult Oncology Development for the Benefit of Children and Adolescents With Cancer - An ACCELERATE Multistakeholder Consensus.
Clin Pharmacol Ther;
115(1): 36-41, 2024 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37885401
5.
Chimeric Antigen Receptor (CAR) T-Cell Products for Pediatric Cancers: Why Alternative Development Paths Are Needed.
J Clin Oncol;
42(3): 253-257, 2024 01 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-38011605
6.
Paediatric Strategy Forum for medicinal product development of DNA damage response pathway inhibitors in children and adolescents with cancer: ACCELERATE in collaboration with the European Medicines Agency with participation of the Food and Drug Administration.
Eur J Cancer;
190: 112950, 2023 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-37441939
7.
Combination Early-Phase Trials of Anticancer Agents in Children and Adolescents.
J Clin Oncol;
41(18): 3408-3422, 2023 06 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-37015036
8.
Impact of the EU Paediatric Medicine Regulation on new anti-cancer medicines for the treatment of children and adolescents.
Lancet Child Adolesc Health;
7(3): 214-222, 2023 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-36682367
9.
Systematic review of clinical drug development activities for neuroblastoma from 2011 to 2020.
Pediatr Blood Cancer;
70(5): e30106, 2023 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-36458672
10.
Cancer research in Europe: a focus on children and young people.
Lancet Oncol;
24(1): 8-9, 2023 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36400105
11.
ACCELERATE Paediatric Strategy Forums: an advance for oncological drug development?
Lancet Oncol;
23(11): 1354-1357, 2022 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-36328007
12.
Early-phase clinical trial eligibility and response evaluation criteria for refractory, relapsed, or progressive neuroblastoma: A consensus statement from the National Cancer Institute Clinical Trials Planning Meeting.
Cancer;
128(21): 3775-3783, 2022 11 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36101004
13.
Rethinking high-risk neuroblastoma treatment.
Pediatr Blood Cancer;
69(8): e29730, 2022 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-35441788
14.
ACCELERATE - Five years accelerating cancer drug development for children and adolescents.
Eur J Cancer;
166: 145-164, 2022 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-35290915
15.
Pediatric Cancer Data Commons: Federating and Democratizing Data for Childhood Cancer Research.
JCO Clin Cancer Inform;
5: 1034-1043, 2021 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-34662145
16.
Second Paediatric Strategy Forum for anaplastic lymphoma kinase (ALK) inhibition in paediatric malignancies: ACCELERATE in collaboration with the European Medicines Agency with the participation of the Food and Drug Administration.
Eur J Cancer;
157: 198-213, 2021 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-34536944
17.
Randomized Trial of Two Induction Therapy Regimens for High-Risk Neuroblastoma: HR-NBL1.5 International Society of Pediatric Oncology European Neuroblastoma Group Study.
J Clin Oncol;
39(23): 2552-2563, 2021 08 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-34152804
18.
Phase 1 dose-escalation and pharmacokinetic study of regorafenib in paediatric patients with recurrent or refractory solid malignancies.
Eur J Cancer;
153: 142-152, 2021 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-34157616
19.
A global approach to long-term follow-up of targeted and immune-based therapy in childhood and adolescence.
Pediatr Blood Cancer;
68(7): e29047, 2021 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-33860611
20.
A nomogram of clinical and biologic factors to predict survival in children newly diagnosed with high-risk neuroblastoma: An International Neuroblastoma Risk Group project.
Pediatr Blood Cancer;
68(3): e28794, 2021 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-33205902